期刊文献+

沈阳地区孕中期产前筛查母血清标志物水平中位数的探讨 被引量:6

下载PDF
导出
摘要 目的:建立沈阳地区孕中期母血清标志物水平的中位数。方法:2001年1月~2003年12月沈阳市内5区及苏家屯、东陵、新城子3个郊区孕中期产前筛查的孕妇24715例,采用时间分辨免疫荧光法对孕妇血清中甲胎蛋白(hAFP)、游离β-人绒毛膜促性腺激素(FreehCGβ)进行检测,分别按孕龄确定其中位数并与软件给定的西方白种人群相应的中位数进行比较。结果:经过体重校正前后,沈阳地区孕妇血清标志物的中位数值与Multicalc软件内嵌参数源人群(欧洲高加索人)有差异(16~19周)。结论:人种和体重对标志物水平均有影响,各地区实验室应该建立自己的中位数并且重视体重的校正,从而提高筛查质量。
出处 《中国妇幼保健》 CAS 北大核心 2005年第9期1141-1143,共3页 Maternal and Child Health Care of China
  • 相关文献

参考文献8

  • 1鲍培忠,吴亚农,顾青,柯瑞娥,洪庆,陶春瑾,黄季敏,张晓频.孕妇血清标记物用于严重胎儿缺陷的产前筛选[J].中华妇产科杂志,1997,32(11):649-651. 被引量:42
  • 2鲍培忠.多种血清标记物在产前筛查中作用的综合评价[J].国外医学(计划生育分册),1999,18(2):74-78. 被引量:56
  • 3庞泓,冯光,宋奉霞,康云玲,张丽.孕妇血清标志物用于出生缺陷的产前筛查[J].中国优生与遗传杂志,2002,10(6):99-100. 被引量:12
  • 4卓乐雯,廖灿,宋淑本,涂新枝.唐氏综合征产前筛查研究[J].中国实用妇科与产科杂志,2004,20(7):414-416. 被引量:48
  • 5Hsu JJ, Hsieh TT, Hsieh FJ. Down' s syndrome screening in an Asian populatin using alpha - fetoprotein and free β - hCG: a report of the Taiwan Down' s syndrome screening group. Obstet Gynecol, 1996, 87(6) : 943 -947.
  • 6Wald NJ, Cuckle H, Brock JH, Peto R, Polani PE, WoodfrodFP. Maternal serum- alpha- fetoprotein measurement in antenatal screening for anencephaly and spina bifida in early pregnancy. Report of U. IC collaborative study on alpha - fetoprotein in relation to neural -tube defects, lancet, 1977, 1 (8 026) : 1 323 - 1 332.
  • 7Macri JN, Kasturi RV, Krantz DA, Cook E J, Larsen JW. Maternal serum alpha - fetoprotein (MsAFP) patient - specific risk reporting:its use an misuse. Am J Hum Genet, 1990, 46:587-590.
  • 8Parvin CA, Gray DL, Kessler G. Influence of assay method differences on multiple of the median distributions : maternal serum alpha - fetoprotein as an example. Clin Chem, 1991, 37 (5) : 637 -642.

二级参考文献15

  • 1鲍培忠,当代医师杂志,1996年,1期,3页
  • 2李竹,出生缺陷监测(第2版),1993年,1页
  • 3Hsu J J, Hsieh TT, Hsieh FJ. Down' s syndrome screening in an Asian population using alpha-fetoprotein and free β-HCG: a report of the Taiwan Down' s syndrome screening group. Obstet Gynecol,1996,87 (6): 943-947
  • 4Cuckle HS,Wald NJ ,Thompson SG. Estimating a woman's risk of having a pregnancy associated with Down' s syndrome using her age and serum alpha-fetoprotein level. Br J Obstet Gynaecol, 1987,94(5): 387-402
  • 5Chik L, Spencer K, Johnson MP, et al. Precise gaussian distribution functions of maternal serum α-fetoprotein and free β-subunit of human chorionic gonadotropin for trisomy 21 screening:improved accuracy for patient counseling. Am J Obstet Gynecol, 1997
  • 6O'Brien WF,Knuppel RA, Torres C, et al. Potential prenatal predictions of Down' s syndrome: a statistical analysis. Am J Obstet Gynecol, 1990,163(6 Pt 1) : 1796-1798
  • 7Hsu JJ,Hsieh TT, Soong YK, et al. Comparison of Down's syndrome screening strategies in Asians combining serum free betahCG and alpha-fetoprotein with maternal age. Prenat Diagn, 1997,17(8) :707-716
  • 8Spencer K. Screening for Down' s syndrome: the role of intact hCG and free subunit measurement. Scand J Clin Lab Invest, 1993,53(suppl 216): 79-96
  • 9Hsu J J, Chiu TH, Chen KC, et al. Maternal serum alpha-fetoprotein levels between 13 and 24 weeks' gestation. Chang Gung Med J,1994,17 (12): 309-315
  • 10Triple marker screening for trisomy 21, trisomy 18 and open neural tube defects in singleton pregnancies of native Japanese pregnant women. J Obstet Gynaecol Res,2000,12:26

共引文献141

同被引文献38

引证文献6

二级引证文献46

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部